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A B S T R A C T
Multiple sclerosis (MS) is one of the most common causes of neurological disability
in early adulthood. The current literature is interested in identifying biological or DNA
markers associated with genetic susceptibility to MS. The aim of this study is to investi-
gate, by means of Bayesian statistical inference, whether the presence of Gc2 (Gc =
group-specific component) and/or EsD1 (EsD = esterase D) alleles affects MS suscepti-
bility. Gc and EsD are two classical genetic markers, being the first a serum protein
polymorphism, the latter an isoenzyme polymorphism. The interest of the proposed sta-
tistical approach of searching for MS susceptibility genes relies on the analysis of two
different functions, one function being inferred from our results on 56 unrelated pa-
tients from central Italy affected by MS, the other one from Italian and worldwide epi-
demiological data. The graphical analysis suggests that MS susceptibility is influenced
by both Gc2 and EsD1 alleles; and EsD1 allele is more informative than Gc2. These re-
sults point out the advantages of the Bayesian approach in searching for susceptibility
genes. Furthermore, the significant association between the considered alleles and the
susceptibility to MS suggests possible hypotheses about the pathogenesis of the disease.
Introduction
Multiple sclerosis (MS) is a chronic in-
flammatory disease of the central ner-
vous system, of unknown aetiology, char-
acterised by T-cell mediated myelin
destruction. An etiological role for genetic
factors was proposed about 100 years ago
by Eichorst who labelled MS as an inheri-
ted, transmissible disease1. Genetic sus-
ceptibility to autoimmune demyelinisa-
tion has been postulated and several
studies, using both population associa-
tion and family linkage methods, have
77
Received for publication July 10, 2001
been carried out to identify and localise
genes responsible for this susceptibility2.
Genetic contribution to MS aetiology has
been investigated by means of classical
association and linkage methods and by
clinical concordance rates between mo-
nozygotic and dizygotic twins. These lat-
ter studies have shown a 25–30% concor-
dance rate in monozygotic but a much
lower rate (2–5%) in dizygotic twins3 and
in non-twin siblings4. Furthermore, a hi-
gher disease incidence in women that in
men (2:1) has been observed.
Investigators have focused on genetic
loci recognised to play a major role in the
immune response, that is human leuko-
cyte antigen genes5,6 and T-cell receptor
genes7,8. Minor areas of study concern
immunoglobulin10,11 and myelin basic
protein genes12. Furthermore, previous
studies, by our group, on serum proteins
and enzyme polymorhisms have shown
remarkable differences between patients
and healthy controls concerning Gc2 (2 =
13.15; p<0.005; d.f.=2) and EsD1 (2 =
9.43; p<0.01; d.f.=2) alleles of the two
polymorphic systems Gc (group-specific
component) and EsD (esterase D). A rela-
tive risk (r.r.) of 3.23 in developing MS
was calculated for the Gc2 phenotype and
of 4.53 for the EsD1 phenotype13,14.
The Gc gene, which encodes the vita-
min D-binding protein (DBP), maps to
chromosome 4q12. Polymorphisms in this
gene give rise to three major electropho-
retic variants of the DBP serum glyco-
protein, which differ by amino acid sub-
stitutions as well as attached polysaccha-
ride structures15. These variants of DBP
are termed Gc1 fast (Gc1f), Gc1 slow
(Gc1s), and Gc2, because before the iden-
tification of its function as a transporter
of vitamin D16, this plasma protein was
known as group-specific component (Gc).
The erythrocyte isoenzyme EsD, with un-
known function, is codified by two iso-
valent alleles (EsD1 and EsD2) into a lo-
cus of the chromosome 13q14. Although
the region on chromosome 13q14 is sup-
posed to be implicated in bipolar affective
disorder, schizophrenia17, obesity18, no
association between genetic markers and
MS has been yet reported for this chro-
mosome.
The present study aims to reanalyse
our previous results13,14 to investigate the
advantages of a strictly Bayesian ap-
proach in searching for susceptibility
genes. In particular, it has been tested
the selectivity of the Gc2 and EsD1 al-
leles for the susceptibility to MS. The in-
terest of the proposed statistical ap-
proach relies on the analysis of two
functions, one function being deducted
from unrelated patients from central It-
aly affected by MS, the other one from
Italian and worldwide epidemiological
data. In fact, the Bayesian approach does
not require the use of a group genetically




Our statistical inference is based on
two sets of empirical data. The first one is
a random sample from our case history,
ethnically and geographically homoge-
neous, of unrelated 56 patients from the
region Abruzzi in Central Italy13,14, af-
fected by MS diagnosed according to the
Poser criteria19 (Table 1). We detected
EsD and Gc phenotypes in these patients
by cellulose acetate electrophoresis13,14.
The second set of data summarizes the
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TABLE 1
OUR CASE HISTORY VS PRESENCE AND






EsD1 present 34 21 55
EsD1 absent 1 0 1
Total 35 21 56
available Gc2 and EsD1 allele frequen-
cies and MS incidence in 18 Italian re-
gions and provinces (Table 2). The de-
tailed frequency values for the different
Italian regions and provinces were re-
ported by Piazza et al.20 and in reviews of
the world distribution of classic mar-
kers21,22. The MS incidence values for the
same populations were drawn from epi-
demiological studies23–25.
Object and method of the Bayesian
inference
In order to evaluate the possible asso-
ciation between the susceptibility to MS
and the presence of: 1) the Gc2 allele re-
gardless of the EsD system; 2) the EsD1
allele regardless of the Gc system; 3) both
Gc2 and EsD1 alleles, we have considered
the probability distribution F( ,) for the
random vector ( ,). The components of 
were the conditional probabilities a, b, r
which measure the chance that a person
chosen at random is affected by MS if it is
known that he/she has: 1) the Gc2 allele
without knowledge of the EsD system, 2)
the EsD1 allele without knowledge of the
Gc system, 3) both Gc2 and EsD1 alleles,
respectively. The components of  are s, g,
t which denote the chance that one was a
MS patient, one had the Gc2 allele, one
had the EsD allele, respectively. The ob-
ject of our inference was  .
The problem was solved by dF( /sam-
ple) = (1/18) * i dG( /i, sample), where
dG( /i, sample) was obtained by the
Bayes’ theorem:





( ) ( )
( ) ( )




i = 1,..., 18; dG( ,i) was the prior and
V(i/ , sample) the Likelihood. The prior
79
M. Di Bacco et al.: Gc and EsD in Multiple Sclerosis, Coll. Antropol. 26 (2002) 1: 77–84
TABLE 2
FREQUENCIES OF THE ESD1 AND GC2 ALLELES AND MS INCIDENCE IN DIFFERENT








Trentino 0.855 0.278 38
Emilia 0.861 0.281 39
Ferrara 0.865 0.266 69
Bologna 0.854 0.329 39
L’Aquila 0.850 0.428 53
Palermo 0.845 0.281 43
Sicilia 0.841 0.225 53
Lombardia 0.865 0.262 24
Veneto 0.856 0.247 20
Padova 0.858 0.257 21
Toscana 0.857 0.280 29
Campania 0.854 0.246 72
Liguria 0.862 0.275 29
Puglia 0.891 0.435 31
Basilicata 0.846 0.494 31
Sardegna 0.883 0.319 150
Italia (without Sardegna) 0.883 0.319 150
was estimated by utilising the allele fre-
quencies and relative incidence of MS in
different Italian regions and provinces re-
ported in literature. The Likelihood was
calculated by considering the sample as
the outcome of 56 random choice from the
population of our MS patients classified
according to Present – Absent with re-
gard to Gc2 and EsD1 (multinomial dis-
tribution).
DF( , sample) was not analytically ex-
plicitable; therefore, it was only possible
to do numerical tabulations of the prior
and likelihood functions for each of the
triplets (si, gi, ti), i = 1,..., 18. Tabulation of
dG( , i, sample) was then still obtained
with s = si, g = gi, t = ti.; finally we deduced
dF( , sample) by averaging such tabula-
tions. By means of three numerical inte-
gration of dF( , sample) with respect to b,
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TABLE 3
FREQUENCIES OF THE ESD1 AND GC2 ALLELES AND MS INCIDENCE








Denmark 0.923 0.217 33
Finland 0.889 0.255 30
France 0.878 0.282 62
Germany 0.877 0.283 57
Ireland 0.845 0.212 16
Italy 0.858 0.292 58
Holland 0.880 0.264 36
Norway 0.918 0.343 32
Poland 0.929 0.256 21
Sweden 0.867 0.296 51
Swiss 0.883 0.269 61
Great Britain 0.917 0.332 24
Russia 0.855 0.218 8
Israel 0.788 0.172 3
Iraq 0.776 0.257 1
India 0.683 0.157 1
Taiwan 0.642 0.267 2
Japan 0.680 0.292 3
Korea 0.869 0.257 3
Turkey 0.914 0.102 3
South Africa 0.731 0.239 34
Canada 0.866 0.257 7
Texas 0.906 0.260 22
United States 0.616 0.230 5
Chile 0.791 0.139 2
Venezuela 0.901 0.271 74
r or a, r, or a, b we were able to have an
accurate graphical representation of the
marginal probability distributions for
random numbers a, b, r, respectively.
Automatic procedure and sensitivity
analysis
The numerical problem had been gra-
phically solved by means of a dedicated
computerised program in MATLAB envi-
ronment (Mathworks, Inc.).
Taking into account that our statisti-
cal inference is based on two sets of heter-
ogeneous data we have investigated the
sensitivity of the results to the choice of
the prior by using the same automatic
procedure. In particular, we have used
Gc2 andEsD1 allele frequencies21,22 and
epidemiological data24,25 from 26 world-
wide countries (Table 3).
Results
Figure 1 shows the probability distri-
butions dFa (. /), dFb (. /), dFr (. /) obtained
by the marginalization of dF ( / sample).
They represent the degree of confidence
on the values of probability of MS suscep-
tibility if 1) allele Gc2 is present; 2) allele
EsD1 is present; 3) both alleles are pres-
ent, respectively.
The graphical analysis suggests that
the susceptibility to MS is influenced by
both the Gc2 and EsD1 alleles. This is ev-
ident because the maximum probability
smax (Figure 1) is left-shifted respect to
the modal points of the distribution. Fur-
thermore, we observe that EsD1 allele is
more informative than Gc2 allele and
that co-presence of both alleles is even
more informative.
The usefulness of the Bayesian ap-
proach is confirmed by sensitivity analy-
sis carried out on allele frequencies and
epidemiological data from world wide dis-
tributed populations. In fact obtained re-
sults show a fully comparable pattern
(Figures 1 and 2).
Discussion
Recently, there is an increasing inter-
est in the application of the Bayesian sta-
tistics in many genetic areas26,27 such as
linkage mapping28. In fact, Bayesian ana-
lysis is simple to interpret. Each quantity
of interest is described by a posterior dis-
tribution which summarises the resear-
cher knowledge in light of the empirical
evidence, and these hypotheses of inter-
est are evaluated by interpreting appro-
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Fig. 1. Italian regions and provinces (n=18 ).
1 = FDP dFa (. /); 2 = FDP dFb (. /);








Fig. 2. World countries (n=26).
1 = FDP dFa (. /); 2 = FDP dFb (. /);
3 = FDP dFr (. /)
priate features of the posterior distribu-
tion.
In the present case, the quantities of
interest are the probabilities  = (a, b, r),
which were chosen to evaluate the associ-
ation between MS and Gc2 and EsD1 al-
leles. We built the joint posterior distri-
bution of a, b, r using the empirical data
reported in Tables 1 and 2. The hypothe-
sis about the association between MS and
the alleles was then evaluated by graphi-
cal examination of some characteristics of
the posterior distribution. The computa-
tional problem was solved with appropri-
ate computer implementation.
More specifically, our procedure invol-
ved the following steps:
a) to assign the prior distribution con-
nected with the vector  = (a, b, r), which
was modelled by using data on EsD and
Gc allele frequencies and MS incidence
rates;
b) to built up the likelihood function
utilising a classic multinomial model;
c) to calculate the marginal probabil-
ity distribution function for a, b, r, by us-
ing the posterior probability distribution
functions obtained by the Bayes’ theorem.
Results support our hypothesis that in
presence of Gc2, or EsD1, or Gc2 and
EsD1, the probability of susceptibility to
MS is higher than that evaluated in the
absence of such information about the re-
spective presences. The maximum proba-
bility of MS susceptibility, assessed with
the population data in Table 2, is left-
shifted with respect to the posterior dis-
tributions relative to a, b, r.
Our results, graphically represented
in Figure 1, also demonstrate that the al-
leles together have a greater influence on
the susceptibility to MS than each allele
considered separately. In fact, the mode
of the posterior distribution for Gc2 and
EsD1 together was to the left of those of
the posterior distribution for Gc2 and
EsD1. Furthermore, if we consider the
two respective modes, the EsD1 allele
showed a greater influence than the Gc2
allele. However, the fact that Gc and EsD
data together better predict Ms does not
necessarily indicate that there is an in-
teractive effect of these genes on MS.
It is not easy to clarify the causes of
the possible associations between 1) Gc2
and MS, and 2) EsD1 and MS, suggested
by our Bayesian analysis. An interesting
hypothesis could be related to the study
by Petrini and co-workers29, which re-
vealed the presence of Gc in membrane
receptors of T lymphocytes. More pre-
cisely, this research localised Gc in the re-
ceptor complex for the Fc portion of the G
immunoglobulin. These data could be sig-
nificant in view of the pathogenetic role of
T lymphocytes in MS30, as indicated by
their presence in acute myelin lesions in
humans31, or in the most accredited ani-
mal model of MS, experimental allergic
encephalomyelitis. Another hypothesis
about the possible role of Gc2 in MS sus-
ceptibility is based on the fact that the Gc
system is a protein vector of vitamin D, a
factor able to hinder the onset of EAE32.
An altered metabolism of vitamin D could
interfere with the activation of T lympho-
cytes33, which represent a direct target
for calcitriol34.
It is even more difficult to interpret
the possible link between EsD1 and MS,
since the function of EsD is still un-
known. However, EsD has been identified
with S-formylglutathione hydrolase35,36,
and therefore is possibly involved in the
function of the cell antioxidant system.
Hence, our results could be in agreement
with the hypothesis suggested by Cala-
brese and co-workers37, that a compro-
mise of the antioxidant mechanisms is in-
volved in the pathogenesis of MS. This
pathogenetic interpretation could be sup-
ported by epidemiological data, such as:
1) the increased incidence of MS in popu-
lations that consume high proportion of
animal fat38, 2) the decreased level of
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linoleic acid39, and 3) the increased con-
centration of malondialdehyde in the
blood of MS patients40.
In conclusion, the obtained results in-
dicate that the Bayesian approach in
searching for susceptibility genes has re-
vealed useful. The significant association
between the Gc2 and EsD1 alleles and
the susceptibility to MS suggests possible
hypotheses about the pathogenesis of the
disease. Our results could confirm the hy-
pothesis that MS is a polygenic and mul-
tifactorial disease, taking into account
the possible role of vitamine D and oxida-
tive stress in its phenotypic expression.
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BAYESOV PRISTUP POTRAZI ZA PREDISPOZICIJSKIM GENIMA:
GC1 I ESD1 ALELI I MULTIPLA SKLEROZA
S A @ E T A K
Multipla skleroza (MS) jedan je od naj~e{}ih uzroka neurolo{kog invaliditeta u ra-
noj odrasloj dobi. Dana{nja istra`ivanja usmjerena su identifikaciji ili biolo{kih ili
DNK markera koji su povezani s genetskom predispozicijom za MS. Cilj je ovog istra-
`ivanja ustanoviti putem Bayesove statistike je li prisustvo alela Gc2 (Gc = kompo-
nenta specifi~na za skupinu) i/ili EsD1 (EsD = D esteraza) predisponira razvoj MS-a.
Gc i EsD su dva klasi~na genska markera, prvi ukazuje na polimorfizam serumskog
proteina a drugi na polimorfizam izoenzima. U potrazi za genima koji predisponiraju
razvoj MS-a predlo`eni statisti~ki pristup zasniva se na analizi dvije razli~ite funkcije.
Prva funkcija proizi{la je iz na{ih prethodnih rezultata dobivenih na 56 nesrodnih bo-
lesnika iz sredi{nje Italije oboljelih od MS, dok druga proizlazi iz epidemiolo{kih po-
dataka koji se odnose na Italiju te drugih populacija {irom svijeta. Grafi~ka analiza
sugerira da je predispozicija za MS pod utjecajem i Gc2 i EsD1 alela, pri ~emu je EsD1
alel informativniji od Gc2. Ovi rezultati ukazuju na prednost Bayesovog pristupa u
potrazi za predispozicijskim genima. [tovi{e, zna~ajna povezanost izme|u razmatra-
nih alela i MS-a sugerira mogu}e hipoteze o patogenezi ove bolesti.
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